Ethereum Upgrade vs XRP Legal Woesby John Darbie 13.02.2024The Ethereum upgrade scheduled for March brings optimism, while XRP faces challenges in its SEC lawsuit. The market awaits developments ...
Retik Finance: The $0.11 Crypto Making Wavesby John Darbie 13.02.2024Retik Finance, a new cryptocurrency priced at $0.11, has caught the attention of top Solana and Ethereum investors. With innovative ...
Amazon Strips Dolby Features from Prime Video’s Budget Tierby Lilu Anderson 13.02.2024Amazon has quietly removed Dolby Vision HDR and Dolby Atmos support from its ad-supported Prime Video tier, forcing users to ...
Dark Future: AI Uncontrolled Intelligence Threatsby Lilu Anderson 13.02.2024Artificial intelligence expert warns of risks and challenges posed by uncontrolled AI autonomy, emphasizing the need for safeguards and human ...
Google Warns of AI App Privacy Risks: Protect Your Privacy Now!by Lilu Anderson 13.02.2024Google warns Android and iPhone users of security risks in AI apps, urging caution in sharing sensitive information during conversations ...
Google Play Spy Apps Exposed: Stay Safe!by Lilu Anderson 13.02.2024Security researchers have discovered 12 Android apps with malicious code that are designed for espionage. These apps, including one posing ...
EV Market Concerns: Tesla and Ford Face Hurdlesby Mark Eisenberg 13.02.2024Analysts at RBC Capital Markets express concerns over the lack of growth in the EV market, with slower growth for ...
Top Stocks Beat S&P 500: Unlock Wealth with ROICby Mark Eisenberg 12.02.2024Investing in companies with high ROICs can potentially lead to better returns than index funds. Consider the long-term financial performance ...
Big Lots Slumps: Analysts Sound Alarm Amid Financial Woesby Mark Eisenberg 12.02.2024Shares of discount retailer Big Lots plummeted 27.6% after an analyst downgrade and concerns about its financial situation. The stock's ...
Gilead’s $4.3B Bet on CymaBay’s Liver Drugby Mark Eisenberg 12.02.2024Gilead Sciences plans to acquire CymaBay Therapeutics for $4.3 billion, expanding their liver disease portfolio. The deal is expected to ...